Targeting of nucleotide-binding proteins by HAMLET—a conserved tumor cell death mechanism

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Oncogene

• Publication date

  2016-02-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/onc.2015.144PMID 26028028
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The molecular motor F-ATP synthase is targeted by the tumoricidal protein HAMLET.

  2015cited by this paper
• Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies

  2014cited by this paper
• Prevention and treatment of colon cancer by peroral administration of HAMLET (human α-lactalbumin made lethal to tumour cells)

  2013cited by this paper
• A Unifying Mechanism for Cancer Cell Death through Ion Channel Activation by HAMLET

  2013cited by this paper
• Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer.

  2012cited by this paper
• AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity.

  2011cited by this paper
• Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase

  2011cited by this paper
• Conserved features of cancer cells define their sensitivity to HAMLET-induced death; c-Myc and glycolysis

  2011cited by this paper
• Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity

  2011cited by this paper
• HAMLET Binding to α-Actinin Facilitates Tumor Cell Detachment

  2011cited by this paper
• mTOR kinase inhibition causes feedback-dependent biphasic regulation of AKT signaling.

  2011cited by this paper
• Non-ATP competitive protein kinase inhibitors.

  2010cited by this paper
• Arf GAPs: Gatekeepers of vesicle generation

  2010cited by this paper
• HAMLET treatment delays bladder cancer development.

  2010cited by this paper
• Inhibition of mutated, activated BRAF in metastatic melanoma.

  2010cited by this paper
• Chemical biology of natural indolocarbazole products: 30 years since the discovery of staurosporine

  2009cited by this paper
• Changes in Proteasome Structure and Function Caused by HAMLET in Tumor Cells

  2009cited by this paper
• Oncogene addiction.

  2008cited by this paper
• Translation of the Philadelphia chromosome into therapy for CML.

  2008cited by this paper
• Rap1a Is a Key Regulator of Fibroblast Growth Factor 2-Induced Angiogenesis and Together with Rap1b Controls Human Endothelial Cell Functions

  2008cited by this paper
• Amyloidogenic peptide homologous to β-domain region of α-lactalbumin

  2007cited by this paper
• Amyloidogenic peptide homologous to beta-domain region of alpha-lactalbumin.

  2007cited by this paper
• Cloning, genomic organization, and tissue-specific expression of the RASL11B gene.

  2007cited by this paper
• Bladder cancers respond to intravesical instillation of (HAMLET human α‐lactalbumin made lethal to tumor cells)

  2007cited by this paper
• Rapid identification of 14-3-3-binding proteins by protein microarray analysis.

  2006cited by this paper
• Targeting Tyrosine Kinases in Cancer: The Second Wave

  2006cited by this paper
• Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice

  2006cited by this paper
• Compartmentalized Ras/MAPK signaling.

  2006cited by this paper
• Analysis of mTOR signaling by the small G‐proteins, Rheb and RhebL1

  2005cited by this paper
• Human α-Lactalbumin Made Lethal to Tumor Cells (HAMLET) Kills Human Glioblastoma Cells in Brain Xenografts by an Apoptosis-Like Mechanism and Prolongs Survival

  2004cited by this paper
• UCSF Chimera—A visualization system for exploratory research and analysis

  2004cited by this paper
• Treatment of skin papillomas with topical alpha-lactalbumin-oleic acid.

  2004cited by this paper
• A Novel Human Nucleolar Protein, Nop132, Binds to the G Proteins, RRAG A/C/D*

  2004cited by this paper
• Ras proteins: different signals from different locations

  2003cited by this paper
• HAMLET Interacts with Histones and Chromatin in Tumor Cell Nuclei*

  2003cited by this paper
• Hitting the Target: Emerging Technologies in the Search for Kinase Substrates

  2002cited by this paper
• The Protein Kinase Complement of the Human Genome

  2002cited by this paper
• ATPases as drug targets: learning from their structure

  2002cited by this paper
• Rab proteins as membrane organizers

  2001cited by this paper
• Small GTP-binding proteins.

  2001cited by this paper
• Printing proteins as microarrays for high-throughput function determination.

  2000cited by this paper
• Identification of Guanine Nucleotide Exchange Factors (GEFs) for the Rap1 GTPase

  2000cited by this paper
• Conversion of alpha-lactalbumin to a protein inducing apoptosis.

  2000cited by this paper
• Apoptosis induced by a human milk protein.

  1995cited by this paper
• Different susceptibility of protein kinases to staurosporine inhibition. Kinetic studies and molecular bases for the resistance of protein kinase CK2.

  1995cited by this paper
• Small GTP-binding proteins.

  1992cited by this paper
• A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse.

  1990cited by this paper
• Potent and Specific Inhibitors of Protein Kinase C of Microbial Origin

  1990cited by this paper
• Properties of a Murine Sarcoma Virus1

  1970cited by this paper
• Properties of a murine sarcoma virus.

  1970cited by this paper
• An Unidentified Virus which causes the Rapid Production of Tumours in Mice

  1964cited by this paper
• Molecular Systems Biology Peer Review Process File Construction of Human Activity-based Phosphorylation Networks Transaction Report

  year unknowncited by this paper

• Rapid ER remodeling induced by a peptide–lipid complex in dying tumor cells

  2025cites this paper
• Clinical and molecular response to alpha1‐oleate treatment in patients with bladder cancer

  2024cites this paper
• Assessing the Therapeutic Impacts of HAMLET and FOLFOX on BRAF-Mutated Colorectal Cancer: A Study of Cancer Cell Survival and Mitochondrial Dynamics In Vitro and Ex Vivo

  2024cites this paper
• BAMLET (Bovine α-lactalbumin made lethal to tumor cells) inhibits autophagy flux and induces apoptosis via down-regulation of protein kinase CK1α and attenuation of the AKT/p-ß-catenin (S552) pathway in RAS-mutated human colorectal HCT 116 cells

  2023cites this paper
• A Tumoricidal Lipoprotein Complex Electrostatically Stabilized on Mesoporous Silica as Nanotherapeutics and Nanoadjuvant for Potentiating Immunotherapy of Triple Negative Breast Cancer

  2023cites this paper
• HAMLET effect on cell death and mitochondrial respiration in colorectal cancer cell lines with KRAS/BRAF mutations

  2023cites this paper
• Lipid bilayer composition as a determinant of cancer cell sensitivity to tumoricidal protein‐lipid complexes

  2022cites this paper
• A scientific journey from discovery to validation of efficacy in cancer patients: HAMLET and alpha1-oleate

  2021cites this paper
• Cytotoxic Lactalbumin-Oleic Acid Complexes in the Human Milk Diet of Preterm Infants

  2021cites this paper
• Bladder cancer therapy using a conformationally fluid tumoricidal peptide complex

  2021cites this paper
• α-Lactalbumin, Amazing Calcium-Binding Protein

  2020cites this paper
• Gold/alpha-lactalbumin nanoprobes for the imaging and treatment of breast cancer

  2020cites this paper
• UEG Week 2020 Poster Presentations

  2020cites this paper
• Bio-Naive Crohn's Disease Patients with Long-Standing Disease Benefit from Ustekinumab Treatment: Real World Experience

  2020cites this paper
• Effect of Alpha-Lactalbumin and Lactoferrin Oleic Acid Complexes on Chromatin Structural Organization

  2019cites this paper
• Protein–lipid complexes: molecular structure, current scenarios and mechanisms of cytotoxicity

  2019cites this paper
• Beta-sheet-specific interactions with heat shock proteins define a mechanism of delayed tumor cell death in response to HAMLET.

  2019cites this paper
• The Use of Human, Bovine, and Camel Milk Albumins in Anticancer Complexes with Oleic Acid

  2018cites this paper
• Anticancer Activities of Ferrous and Ferric Ions in Progression, Proliferation, Angiogenesis, Invasion and Metastasis against Cancer and Tumor Cells

  2018cites this paper
• PhosphoPredict: A bioinformatics tool for prediction of human kinase-specific phosphorylation substrates and sites by integrating heterogeneous feature selection

  2017cites this paper
• HAMLET - A protein-lipid complex with broad tumoricidal activity.

  2017cites this paper
• Protein-dependent Membrane Interaction of A Partially Disordered Protein Complex with Oleic Acid: Implications for Cancer Lipidomics

  2016cites this paper
• Behaviour of oleic acid-depleted bovine alpha-lactalbumin made LEthal to tumor cells (BAMLET).

  2016cites this paper
• α-Lactalbumin:Oleic Acid Complex Spontaneously Delivers Oleic Acid to Artificial and Erythrocyte Membranes.

  2015cites this paper
• Protein receptor-independent plasma membrane remodeling by HAMLET: a tumoricidal protein-lipid complex

  2015cites this paper
• Structure and Potential Cellular Targets of HAMLET-like Anti-Cancer Compounds made from Milk Components.

  2015cites this paper